Related references
Note: Only part of the references are listed.Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin
J. L. Slater et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Differential Regulation of Kidney and Spleen Cytokine Responses in Mice Challenged with Pathology-Standardized Doses of Candida albicans Mannosylation Mutants
Luis Castillo et al.
INFECTION AND IMMUNITY (2011)
Recognition and Blocking of Innate Immunity Cells by Candida albicans Chitin
Hector M. Mora-Montes et al.
INFECTION AND IMMUNITY (2011)
Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance
Ronen Ben-Ami et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Genetic Dissection of Azole Resistance Mechanisms in Candida albicans and Their Validation in a Mouse Model of Disseminated Infection
Donna M. MacCallum et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Chitin synthesis and fungal pathogenesis
Megan D. Lenardon et al.
CURRENT OPINION IN MICROBIOLOGY (2010)
Fungal echinocandin resistance
Louise A. Walker et al.
FUNGAL GENETICS AND BIOLOGY (2010)
Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity
K. Niimi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Echinocandin pharmacodynamics: review and clinical implications
Melanie W. Pound et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Breakthrough Invasive Candidiasis in Patients on Micafungin
Christopher D. Pfeiffer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Potency of Anidulafungin Compared to Nine Other Antifungal Agents Tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: Results from the Global SENTRY Antimicrobial Surveillance Program (2008)
Shawn A. Messer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Conserved Fungal LysM Effector Ecp6 Prevents Chitin-Triggered Immunity in Plants
Ronnie de Jonge et al.
SCIENCE (2010)
PKC Signaling Regulates Drug Resistance of the Fungal Pathogen Candida albicans via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90
Shantelle L. LaFayette et al.
PLOS PATHOGENS (2010)
Differential Effects of Inhibiting Chitin and 1,3-β-D-Glucan Synthesis in Ras and Calcineurin Mutants of Aspergillus fumigatus
Jarrod R. Fortwendel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Hsp90 Orchestrates Temperature-Dependent Candida albicans Morphogenesis via Ras1-PKA Signaling
Rebecca S. Shapiro et al.
CURRENT BIOLOGY (2009)
Property Differences among the Four Major Candida albicans Strain Clades
Donna M. MacCallum et al.
EUKARYOTIC CELL (2009)
Exposure to caspofungin activates Cap and Hog pathways in Candida albicans
Judy Kelly et al.
MEDICAL MYCOLOGY (2009)
Paradoxical echinocandin activity: a limited in vitro phenomenon?
Nathan P. Wiederhold
MEDICAL MYCOLOGY (2009)
Early-Expressed Chemokines Predict Kidney Immunopathology in Experimental Disseminated Candida albicans Infections
Donna M. MacCallum et al.
PLOS ONE (2009)
Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease
Leah E. Cowen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Chitin, Chitinases and Chitinase-like Proteins in Allergic Inflammation and Tissue Remodeling
Chun Geun Lee
YONSEI MEDICAL JOURNAL (2009)
Hsp90 Orchestrates Stress Response Signaling Governing Fungal Drug Resistance
Leah E. Cowen
PLOS PATHOGENS (2009)
Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin
Sheena D. Singh et al.
PLOS PATHOGENS (2009)
Chitin regulation of immune responses: an old molecule with new roles
Chun Geun Lee et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Functional analysis of Candida albicans GPI-anchored proteins: Roles in cell wall integrity and caspofungin sensitivity
Armel Plaine et al.
FUNGAL GENETICS AND BIOLOGY (2008)
Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy
Nabil Kabbara et al.
HAEMATOLOGICA (2008)
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin:: Analysis and proposal for interpretive MIC breakpoints
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Dynamic, Morphotype-Specific Candida albicans beta-Glucan Exposure during Infection and Drug Treatment
Robert T. Wheeler et al.
PLOS PATHOGENS (2008)
Stimulation of chitin synthesis rescues Candida albicans from echinocandins
Louise A. Walker et al.
PLOS PATHOGENS (2008)
Increases in SLT2 expression and chitin content are associated with incomplete killing of Candida glabrata by caspofungin
Jason M. Cota et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C-dubliniensis
M. Fleischhacker et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: Six years of global surveillance
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Endoplasmic reticulum α-glycosidases of Candida albicans are required for N glycosylation, cell wall integrity, and normal host-fungus interaction
Hector M. Mora-Montes et al.
EUKARYOTIC CELL (2007)
Immune recognition of candida albicans β-glucan by dectin-1
Neil A. R. Gow et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Resistance to echinocandin-class antifungal drugs
David S. Perlin
DRUG RESISTANCE UPDATES (2007)
Acquired resistance to echinocandins in Candida albicans:: case report and review
Marie-Therese Baixench et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Paradoxical effect of echinocandins across Candida species in vitro:: Evidence for echinocandin-specific and Candida species-related differences
Georgios Chamilos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase
Jennifer Nielsen Kahn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro
Mette D. Jacobsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans
Carol A. Munro et al.
MOLECULAR MICROBIOLOGY (2007)
Sequence resources at the Candida genome database
Martha B. Arnaud et al.
NUCLEIC ACIDS RESEARCH (2007)
Escape of Candida from caspofungin inhibition at concentrations above the MIC (Paradoxical effect) accomplished by increased cell wall chitin;: Evidence for β-1,6-glucan synthesis inhibition by caspofungin
David A. Stevens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility
Santosh Katiyar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
A drug-sensitive genetic network masks fungi from the immune system
Robert T. Wheeler et al.
PLOS PATHOGENS (2006)
Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis
M Laverdière et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
In vitro susceptibilities of Candida spp. to caspofungin:: Four years of global surveillance
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1
Sergey V. Balashov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Hsp90 potentiates the rapid evotution of new traits: Drug resistance in diverse fungi
LE Cowen et al.
SCIENCE (2005)
Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: Relationship of MIC to treatment outcome
N Kartsonis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp isolates
S Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice
DM MacCallum et al.
MYCOSES (2005)
Paradoxical effect of caspofungin:: Reduced activity against Candida albicans at high drug concentrations
DA Stevens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling
C Reinoso-Martin et al.
EUKARYOTIC CELL (2003)
Mutations in Fks1p affect the cell wall content of β-1,3-and β-1,6-glucan in Saccharomyces cerevisiae
GJP Dijkgraaf et al.
YEAST (2002)
Usefulness of multilocus sequence typing for characterization of clinical isolates of Candida albicans
ME Bougnoux et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: Pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia
R Petraitiene et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Characterization of the chitin biosynthesis process as a compensatory mechanism in the fks1 mutant of Saccharomyces cerevisiae
LJ García-Rodriguez et al.
FEBS LETTERS (2000)
The cell wall architecture of Candida albicans wild-type cells and cell wall-defective mutants
JC Kapteyn et al.
MOLECULAR MICROBIOLOGY (2000)
Share Paper
